Tysabri Recent News
Shares Pull Back As Problems Pile Up At Perrigo
Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors
Deutsche Bank Echoes Starboard's Sentiment: Perrigo Is Undervalued
Biogen Optionality Looking Attractive; Bernstein Initiates At Outperform
Morgan Stanley Cuts Perrigo's Price Target To $112, Expects Lower Long-Term Growth
Nomura's Takeways From Biogen Idec's Analyst Meeting